Position in ARGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$41,200,407
+$12,871,089 QoQ
Shares Held
44,408
+14.5% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 8%
None 14%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ARGX ranks #38 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,200,407 | 44,408 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $28,329,318 | 38,794 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $30,961,255 | 36,817 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,664,661 | 40,220 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,840,060 | 35,993 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,082,317 | 32,241 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $15,331,335 | 24,929 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,103,965 | 20,484 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,337,614 | 19,388 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,067,273 | 17,950 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,801,326 | 17,878 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $7,895,084 | 16,059 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,427,767 | 13,927 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,101,363 | 13,692 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,930,092 | 13,014 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,842,948 | 10,885 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,763,034 | 9,932 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,304,764 | 10,481 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,832,894 | 5,234 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,578,252 | 5,226 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,658,293 | 5,508 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,076,991 | 7,542 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,361,542 | 8,030 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $2,047,393 | 7,799 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,538,095 | 6,829 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $844,652 | 6,412 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||